Study guide
6.3 Dengue Fever, Arboviral Infections & Leptospirosis
CAMC Regional Medical Registration Examination Part 1 MCQ
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Registration Framework & Test Strategy
1.1 Exam Format, Administration & Caribbean Medical Registration Pathways 1.2 Clinical Reasoning & Single-Best-Answer MCQ Test-Taking Strategy 1.3 Regional Epidemiology & Caribbean Healthcare Context
2 Chapter 2: Internal Medicine: Cardiovascular Disorders
2.1 Acute Coronary Syndromes & Myocardial Infarction Management 2.2 Heart Failure Syndromes & Cardiogenic Shock 2.3 Cardiac Arrhythmias, Conduction Blocks & BLS/ACLS Algorithms 2.4 Valvular Heart Disease, Infective Endocarditis & Hypertension
3 Chapter 3: Internal Medicine: Respiratory Medicine & Critical Care
3.1 Asthma & Chronic Obstructive Pulmonary Disease Exacerbations 3.2 Community-Acquired Pneumonia, Hospital-Acquired Pneumonia & Tuberculosis 3.3 Pulmonary Embolism, Pleural Effusion & Pneumothorax
4 Chapter 4: Internal Medicine: Endocrinology & Metabolic Disorders
4.1 Diabetes Mellitus, Diabetic Ketoacidosis & Hyperosmolar Hyperglycaemic State 4.2 Thyroid Disorders: Thyrotoxicosis, Hypothyroidism & Thyroid Storm 4.3 Adrenal Disorders, Pituitary Pathology & Calcium Homeostasis
5 Chapter 5: Internal Medicine: Gastroenterology, Hepatology & Nephrology
5.1 Upper & Lower Gastrointestinal Bleeding: Evaluation & Management 5.2 Cirrhosis, Portal Hypertension & Hepatic Encephalopathy 5.3 Acute Kidney Injury & Chronic Kidney Disease Staging 5.4 Fluid, Electrolyte & Acid-Base Emergencies
6 Chapter 6: Internal Medicine: Neurology, Haematology & Infectious Diseases
6.1 Stroke, Transient Ischaemic Attack & Acute Neurological Deficits 6.2 Sickle Cell Disease, Haemoglobinopathies & Transfusion Medicine 6.3 Dengue Fever, Arboviral Infections & Leptospirosis 6.4 HIV/AIDS, Opportunistic Infections & Antimicrobial Stewardship
7 Chapter 7: General Surgery: Acute Abdomen & Surgical Emergencies
7.1 Acute Abdomen: Peritonitis, Appendicitis & Acute Cholecystitis 7.2 Intestinal Obstruction, Bowel Ischaemia & Perforated Viscus 7.3 Abdominal Wall Hernias: Inguinal, Femoral, Umbilical & Strangulation 7.4 Upper & Lower GI Surgical Pathology & Postoperative Complications
8 Chapter 8: General Surgery: Trauma Resuscitation, Shock & Critical Care
8.1 ATLS Primary Survey & Hemorrhagic Shock Resuscitation 8.2 Thoracic Trauma: Tension Pneumothorax, Hemothorax & Flail Chest 8.3 Abdominal & Pelvic Trauma: FAST Examination & Damage Control Surgery 8.4 Traumatic Brain Injury, Burns & Wound Management
9 Chapter 9: General Surgery: Surgical Subspecialties & Perioperative Care
9.1 Urological Emergencies: Acute Retention, Renal Colic, Torsion & Hematuria 9.2 Musculoskeletal Trauma: Fractures, Dislocations & Compartment Syndrome 9.3 Preoperative Assessment, Surgical Site Infections & Fluid Management 9.4 Otolaryngology: Ear, Nose, Throat & Upper Airway Emergencies 9.5 Clinical Ophthalmology: Acute Red Eye, Glaucoma & Retinal Emergencies
10 Chapter 10: Obstetrics: Antenatal Care, Labor & Complications
10.1 Routine Antenatal Care, Screening & Fetal Assessment 10.2 Hypertensive Disorders of Pregnancy: Pre-eclampsia & Eclampsia 10.3 Antepartum Haemorrhage: Placenta Praevia & Placental Abruption 10.4 Normal Labor, Labor Dystocia & Obstetric Analgesia
11 Chapter 11: Obstetrics & Gynaecology: Postpartum & Pathology
11.1 Postpartum Haemorrhage, Normal Puerperium Physiology & Postpartum Care 11.2 Ectopic Pregnancy, Miscarriage & Gestational Trophoblastic Disease 11.3 Abnormal Uterine Bleeding & Pelvic Inflammatory Disease 11.4 Contraception, Cervical Cancer Screening & Gynaecological Malignancies 11.5 Obstetric & Gynaecological Instruments & Cervical Specimen Collection (PAP Smear Procedures)
12 Chapter 12: Paediatric Medicine: Neonatal Care, Growth & Nutrition
12.1 Neonatal Resuscitation, APGAR Scoring & Prematurity Complications 12.2 Neonatal Jaundice: Physiological, Pathological & Kernicterus 12.3 Growth Monitoring, Developmental Milestones & Failure to Thrive 12.4 Protein-Energy Malnutrition: Kwashiorkor, Marasmus & Nutritional Deficiencies
13 Chapter 13: Paediatric Medicine: Common Illnesses & Emergencies
13.1 Acute Gastroenteritis, Dehydration Assessment & WHO ORS Protocols 13.2 Paediatric Respiratory Illness: Croup, Bronchiolitis & Asthma 13.3 Childhood Infections, Exanthems & Caribbean Immunisation Schedules 13.4 Paediatric Surgical & Medical Emergencies: Intussusception & Febrile Seizures 13.5 Social Paediatrics, Child Protection & Vulnerable Child Health
14 Chapter 14: Psychiatry: Clinical Assessment & Psychopharmacology
14.1 Depressive Disorders, Bipolar Affective Disorder & Suicide Risk Assessment 14.2 Psychosis, Schizophrenia & Acute Delirium vs Dementia 14.3 Anxiety Disorders, Substance Misuse & Psychotropic Side Effects
15 Chapter 15: Community Health, Epidemiology & Preventive Medicine
15.1 Epidemiological Study Designs, Measures of Association & Bias 15.2 Screening Test Performance: Sensitivity, Specificity, PPV & NPV 15.3 Outbreak Investigation, Levels of Prevention & Caribbean NCD Control
16 Chapter 16: Internal Medicine: Rheumatology, Connective Tissue & Dermatology
16.1 Connective Tissue & Collagen Vascular Diseases 16.2 Bone & Joint Diseases: Non-Traumatic Arthropathies & Metabolic Bone Disorders 16.3 Clinical Dermatology: Common, Inflammatory, Bullous, Malignant & Drug-Induced Dermatoses
17 Chapter 17: Anaesthetics, Intensive Care & Clinical Measurements
17.1 Important Anaesthetic Techniques, Airway Management & Methods of Administration 17.2 Clinical Measurements & Intensive Care Monitoring: Cardiac Output, Arterial Blood Gases & Pulmonary Functions 17.3 Acute Pain Management, Multimodal Analgesia & Critical Care Sedation
6.3 Dengue Fever, Arboviral Infections & Leptospirosis
Key Takeaways Explain This Topic AI
Dengue virus (DENV 1-4, Flaviviridae) transmitted by Aedes aegypti follows a triphasic clinical trajectory (febrile, critical, and recovery phases); the critical phase coincides with defervescence (days 3 to 7) when systemic plasma leakage, rising hematocrit, and Dengue Shock Syndrome (DSS) develop.
The 2009 WHO classification stratifies dengue into Dengue without warning signs, Dengue with warning signs, and Severe Dengue (severe plasma leakage with shock or respiratory distress, severe bleeding, or severe organ impairment AST/ALT >= 1000 U/L).
Dengue with warning signs but no shock requires judicious isotonic crystalloids (5-7 mL/kg/h tapered to 3-5 then 2-3), guided by hematocrit, perfusion and urine output (> 0.5 mL/kg/h); shock needs a separate resuscitation algorithm; NSAIDs, aspirin, and intramuscular injections are strictly contraindicated.
Chikungunya virus is distinguished by debilitating, symmetric polyarthralgia and tenosynovitis that can persist for months to years, whereas Zika virus carries specific risks of Guillain-Barré syndrome in adults and congenital microcephaly in neonates.
Leptospirosis (Leptospira interrogans), a spirochetal zoonosis contracted from floodwater or rodent urine, manifests as a biphasic illness culminating in Weil's disease (triad of jaundice, renal failure, and hemorrhage); non-purulent conjunctival suffusion and hypokalemic nephropathy are pathognomonic clues treated with early IV penicillin G or ceftriaxone.
Last updated: November 2026
Arboviral Epidemiology & Vector Biology in the Caribbean
Vector-borne arboviral diseases represent recurrent, seasonal epidemics throughout the Caribbean basin, driven by tropical climate patterns, urbanization, and the widespread domestic proliferation of the primary vector, Aedes aegypti (and to a lesser extent, Aedes albopictus ). These container-breeding mosquitoes bite predominantly during daylight hours (early morning and late afternoon).
Dengue Virus (DENV): A positive-sense single-stranded RNA virus of the family Flaviviridae , comprising four distinct antigenic serotypes ( DENV-1, DENV-2, DENV-3, DENV-4 ). Infection with one serotype confers lifelong homotypic immunity to that specific serotype, but only transient cross-protection (lasting a few months) against heterologous serotypes.
Antibody-Dependent Enhancement (ADE): When an individual previously infected with one serotype experiences a secondary infection with a different heterologous serotype, pre-existing sub-neutralizing non-protective antibodies bind to the new virions. These antibody-virus complexes facilitate viral entry into monocytes and macrophages via surface Fc-gamma receptors. This produces amplified intracellular viral replication, massive activation of cross-reactive T-cells, and an intense 'cytokine storm' (interleukins IL-6, IL-8, IL-10, TNF-alpha, and VEGF). This inflammatory surge disrupts endothelial glycocalyx integrity, causing acute microvascular hyperpermeability and plasma leakage , which can cause shock or respiratory distress in severe dengue.
Triphasic Clinical Course of Dengue
Dengue is a dynamic illness characterized by three distinct phases: febrile, critical, and recovery.
1. Febrile Phase (Usually 2 to 7 Days)
Presentation: Sudden onset of high continuous fever (39°C to 40°C), accompanied by severe retro-orbital headache, photophobia, intense generalized arthralgia and myalgia (hence the historical designation 'breakbone fever' ), facial flushing, anorexia, and nausea.
Physical Signs: Generalized erythema or a fine macular rash; positive tourniquet test (standard blood pressure cuff inflated midway between systolic and diastolic BP for 5 minutes; ≥ 10 \ge 10 ≥ 10 petechiae per square inch confirms capillary fragility).
Laboratory Findings: Progressive leukopenia (WBC often < 4.0 × 10 9 / L < 4.0 \times 10^9/\text{L} < 4.0 × 1 0 9 / L ), mild thrombocytopenia, and normal hematocrit.
2. Critical Phase (Days 3 to 7, Around Defervescence)
Onset: Coincides with the transition when fever rapidly subsides to normal or subnormal levels (37.5°C to 38.0°C). Many clinicians mistakenly assume defervescence heralds clinical recovery, whereas it marks the window of highest vulnerability to life-threatening plasma leakage lasting 24 to 48 hours.
Pathophysiology: Sudden endothelial hyperpermeability causes plasma extravasation from the intravascular space into serous cavities (pleural spaces, peritoneum, pericardium).
Laboratory Hallmark: Hemoconcentration (hematocrit increases by ≥ 20 % \ge 20\% ≥ 20% above baseline) occurring concurrently with a rapid, precipitous drop in platelet count (often < 100 × 10 9 / L < 100 \times 10^9/\text{L} < 100 × 1 0 9 / L or < 50 × 10 9 / L < 50 \times 10^9/\text{L} < 50 × 1 0 9 / L ).
Warning Signs (WHO 2009 Criteria):
- Severe abdominal pain or tenderness (secondary to gallbladder wall edema or mesenteric ischemia)
- Persistent vomiting or inability to tolerate oral fluids
- Clinical fluid accumulation (pleural effusion on CXR/ultrasound, ascites)
- Mucosal bleeding (epistaxis, gingival bleeding, hematemesis, melena, heavy menorrhagia)
- Lethargy, restlessness, or altered mental status
- Hepatomegaly > 2 cm below the right costal margin
- Laboratory: Rapid rise in hematocrit concurrent with rapid fall in platelet count
- 3. Recovery (Convalescent) Phase (Days 7 to 10)
Extravasated fluid is gradually reabsorbed from serous spaces back into the intravascular compartment over 48 to 72 hours.
General well-being improves, appetite returns, gastrointestinal symptoms abate, and hemodynamic status stabilizes with brisk spontaneous diuresis.
Convalescent Rash: An erythematous, confluent morbilliform rash with distinct spared areas of pale, normal skin—classically termed 'islands of white in a sea of red' —associated with intense generalized pruritus, particularly on the palms and soles.
Physiological sinus bradycardia is common.
Iatrogenic Hazard: Continuing aggressive intravenous fluids during this reabsorption phase causes lethal pulmonary edema and fluid overload .
2009 WHO Classification of Dengue
Classification Clinical Criteria Management Setting
Dengue Without Warning Signs Fever and 2 of: nausea/vomiting, rash, aches/pains, positive tourniquet test, leukopenia Group A outpatient care only if stable, drinking and urinating adequately, with reliable follow-up ; assess admission for pregnancy, coexisting illness or social risk; oral fluids and daily review
Dengue With Warning Signs Dengue fulfilling above criteria PLUS any warning sign (abdominal pain, vomiting, fluid accumulation, mucosal bleed, lethargy, hepatomegaly > 2cm, rising Hct with falling platelets) Inpatient admission (Group B) ; close vital signs and serial hematocrit; titrated IV isotonic crystalloids
Severe Dengue 1. Severe Plasma Leakage: Leading to Dengue Shock Syndrome (narrowed pulse pressure ≤ 20 mmHg \le 20\text{ mmHg} ≤ 20 mmHg , hypotension, CRT > 2s) or fluid accumulation with respiratory distress; 2. Severe Bleeding: As evaluated by clinician (e.g. gross GI hemorrhage); 3. Severe Organ Impairment: Liver AST or ALT ≥ 1000 U/L \ge 1000\text{ U/L} ≥ 1000 U/L , CNS impairment (encephalopathy), myocarditis, or acute renal failure Emergency monitored / ICU care (Group C) ; titrated crystalloids for shock, blood for significant hemorrhage and organ support; fluid boluses depend on perfusion
Management Protocols & Clinical Pitfalls in Dengue
Absolute Contraindications:
Strictly avoid NSAIDs, Aspirin, and Corticosteroids: NSAIDs (ibuprofen, diclofenac, naproxen) and aspirin cause platelet cyclooxygenase-1 inhibition and gastritis, precipitating catastrophic gastrointestinal hemorrhage in thrombocytopenic patients. Corticosteroids provide no mortality benefit and increase bacterial superinfection risk.
Strictly avoid Intramuscular (IM) Injections: High risk of large, painful intramuscular hematomas in coagulopathic/thrombocytopenic patients.
Antipyresis: Prescribe Paracetamol only (maximum 3 g/day in adults; 10–15 mg/kg/dose 6-hourly in children) to avoid hepatotoxicity.
Fluid Titration for Dengue With Warning Signs:
Obtain baseline hematocrit before initiating IV fluids.
Administer isotonic crystalloid (0.9% Normal Saline or Hartmann's / Ringer's Lactate) at 5 to 7 mL/kg/hour for 1 to 2 hours .
If clinical parameters and urine output improve, taper to 3 to 5 mL/kg/hour for 2 to 4 hours , then reduce to 2 to 3 mL/kg/hour for 2 to 4 hours .
Titrate dynamically against hourly urine output (maintain > 0.5 mL/kg/hour ) and serial hematocrit checks every 4 to 6 hours.
Total IV fluid duration should rarely exceed 24 to 48 hours.
Resuscitation of Dengue Shock Syndrome (DSS):
Compensated shock: start isotonic crystalloid 5–10 mL/kg over 1 hour . Hypotensive shock: give 20 mL/kg over 15 minutes , reassessing perfusion frequently and adjusting for comorbidities.
When circulation improves, reduce fluids progressively; do not give shock boluses solely for organ involvement without hypoperfusion.
Persistent shock needs urgent reassessment of perfusion, hematocrit, fluid responsiveness and bleeding. Further crystalloids are preferred; specialist-directed colloid rescue may be considered after inadequate response to repeated crystalloid boluses.
If the hematocrit drops precipitously without clinical hemodynamic recovery, suspect occult internal hemorrhage and transfuse crossmatched packed red blood cells immediately.
Chikungunya & Zika Viruses: Clinical Differentiation
During regional arboviral epidemics, clinicians must distinguish Dengue from Chikungunya and Zika:
Chikungunya Virus (Togaviridae, Alphavirus):
Characterized by abrupt high fever, maculopapular rash, and severe, disabling, symmetric polyarthralgia and tenosynovitis primarily targeting the wrists, small joints of hands, ankles, and knees.
The word Chikungunya is derived from the Makonde language meaning 'that which bends up', describing the stooped posture assumed by sufferers due to excruciating articular pain.
While dengue causes diffuse muscle ache ('breakbone' myalgia), chikungunya produces frank inflammatory joint swelling, effusion, and severe morning stiffness .
Persistent Chikungunya Joint Symptoms: Arthralgia or arthritis can persist for months or years. Manage pain and disability with analgesia, NSAIDs once dengue is excluded, and physiotherapy. Persistent inflammatory arthritis warrants rheumatology assessment; selected patients may need DMARDs such as methotrexate.
Zika Virus (Flaviviridae):
Approximately 80% of infections are asymptomatic; symptomatic illness is usually mild and self-limiting, characterized by low-grade fever, pruritic descending maculopapular rash, mild arthralgia, and bilateral non-purulent conjunctivitis .
Major Complications:
Guillain-Barré Syndrome (GBS): Acute post-infectious autoimmune polyradiculoneuropathy presenting with ascending symmetric flaccid paralysis and areflexia in adults.
Congenital Zika Syndrome: Maternal infection during pregnancy results in viral neurotropism destroying fetal neural progenitor cells, causing severe fetal microcephaly , craniofacial disproportion, intracranial cerebral calcifications, ventriculomegaly, macular chorioretinal atrophy, and arthrogryposis.
Can be sexually transmitted via semen; barrier contraception is recommended following travel to endemic areas.
Leptospirosis ( Leptospira interrogans ) & Weil's Disease
Leptospirosis is a widespread bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira . It is endemic across the Caribbean, where transmission peaks sharply following tropical storms, hurricanes, and heavy rainfall that induce environmental flooding.
Transmission & Pathogenesis
Reservoir hosts (particularly brown rats, Rattus norvegicus , as well as livestock and dogs) harbor spirochetes chronologically within their renal tubules, shedding high concentrations into urine.
Humans contract infection through direct mucosal contact or percutaneous penetration of broken skin (cuts, abrasions) exposed to water, mud, or soil contaminated with infected rodent urine (agricultural workers, sugarcane harvesters, sewer workers, or flood victims).
Clinical Presentation: Biphasic Illness
Septicemic (Leptospiremic) Phase (Days 1 to 7): Abrupt high fever, rigors, headache, retro-orbital pain, severe abdominal pain, and intense calf and lumbar myalgia .
Pathognomonic Physical Sign: Conjunctival suffusion without purulence (bilateral dilatation of conjunctival episcleral vessels without inflammatory exudate or pus). Present in ~50% of cases within the first 48 hours; highly specific when paired with severe calf tenderness.
Immune Phase (Days 8+): Disappearance of spirochetes from blood and emergence of circulating IgM antibodies; can manifest as aseptic meningitis, uveitis, or progression to severe multi-organ dysfunction.
Severe Leptospirosis: Weil's Disease (Icteric Form)
Weil's disease occurs in 5% to 10% of patients and carries a mortality of 15% to 40%.
The Classic Triad of Weil's Disease:
Profound Jaundice: Bright reddish-orange ('rubinic') jaundice caused by extensive hepatic sinusoidal capillaritis and intrahepatic cholestasis. Conjugated hyperbilirubinemia is markedly disproportionate to transaminase elevations (AST and ALT are typically only mildly elevated, < 200–500 U/L, distinguishing it from viral hepatitis where transaminases exceed 1000 U/L).
Acute Kidney Injury (AKI): Direct tubular toxicity and interstitial nephritis. A unique hallmark of early leptospiral nephropathy is an isolated impairment of sodium and potassium reabsorption in the proximal tubule and thick ascending limb , leading to polyuria and profound hypokalemia before progressing to oliguric azotemic renal failure.
Hemorrhagic Diathesis: Diffuse endothelial vasculitis causing widespread petechiae, purpura, epistaxis, and lethal severe pulmonary hemorrhage syndrome (SPHS) . SPHS presents with acute breathlessness, hemoptysis, and bilateral alveolar infiltrates on CXR, representing the leading cause of death in severe leptospirosis.
Diagnostic Evaluation & Pharmacotherapy
Diagnostics: Microscopic Agglutination Test (MAT, the definitive reference serology showing ≥ 4 \ge 4 ≥ 4 -fold rise in titer), IgM ELISA, and real-time PCR in blood (first 7 days) or urine (after day 7).
Pharmacotherapy:
Mild Outpatient Leptospirosis: Oral Doxycycline 100 mg BD for 7 days (or oral Azithromycin 500 mg daily).
Severe Leptospirosis / Weil's Disease: Intravenous Penicillin G 1.5 million units IV every 6 hours for 7 days ; or intravenous Ceftriaxone 1 g to 2 g IV daily for 7 days .
Jarisch-Herxheimer Reaction: Clinicians must monitor patients closely during the first 2 to 12 hours after initiating penicillin or ceftriaxone. Rapid spirochete lysis releases inflammatory endotoxins, triggering acute fever, rigors, tachycardia, and peripheral vasodilatory hypotension. Manage with IV crystalloid resuscitation and supportive antipyresis.
Differential Comparison: Dengue vs. Leptospirosis vs. Chikungunya
Feature Dengue Fever Leptospirosis (Weil's) Chikungunya
Pathogen & Vector / Route Flavivirus; Aedes aegypti mosquito Leptospira interrogans spirochete; floodwater/rodent urine Alphavirus; Aedes aegypti mosquito
Incubation Period 4 to 10 days 5 to 14 days (up to 30 days) 3 to 7 days
Musculoskeletal Focus Diffuse 'breakbone' myalgia/arthralgia Intense calf and lumbar muscle tenderness Severe, symmetric inflammatory polyarthritis
Ocular Manifestation Retro-orbital pain, photophobia Conjunctival suffusion without purulence Mild conjunctivitis
Hematologic Hallmark Leukopenia, thrombocytopenia, hemoconcentration (rising Hct) Leukocytosis with neutrophilia , thrombocytopenia, normal Hct Mild leukopenia, normal hematocrit
Renal & Hepatic Profile Elevated AST > ALT (hepatitis); shock-induced AKI late Hypokalemic non-oliguric AKI ; marked bilirubin elevation with modest AST/ALT Normal renal and liver function
Critical Danger Window Days 3–7 at defervescence (plasma leak shock) Days 5–10 (pulmonary hemorrhage, renal failure) Post-acute persistent arthralgia / arthritis
Primary Treatment Judicious IV crystalloid titration; strictly no NSAIDs IV Penicillin G or Ceftriaxone ; monitor Jarisch-Herxheimer Supportive; NSAIDs after dengue excluded